NCOA4 and central nervous system cancer: Furthermore, consistent with glioma cells, double knockout Par-4−/− MEFs also significantly inhibited RSL3 or ML210-induced degradation of FTH1 and NCOA4 (Fig. 4j and Supplementary Fig. 4e).